Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-2 of  2 results for ""Antigens, CD19""

Your Filters

Publisher : ims health
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

Merck Validates BTK Inhibitors with US$2.7 B ArQule Buy.

Subjects: CD19 antigen; PROTEIN-tyrosine kinases; BIOPHARMACEUTICSMERCK KGaA

  • Source: PharmaDeals Review. Dec2019, Vol. 2019 Issue 12, p77-77. 1p.

Record details

Read More Add to Saved list
×
Periodical

Incyte Pays US$900 M Upfront to Partner with MorphoSys for Tafasitamab.

Subjects: B cell receptors; THERAPEUTICS; CD19 antigen

  • Source: PharmaDeals Review. Jan2020, Vol. 2020 Issue 1, p4-4. 1p.

Record details

Read More Add to Saved list
×
  • 1-2 of  2 results for ""Antigens, CD19""